Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication

Capsid Phosphorylation State and Hepadnavirus Virion Secretion

(2017) Xiaojun Ning et al.   JOURNAL OF VIROLOGY

Infection and Cancer: The Case of Hepatitis B

(2016) Stephen L. Chan et al.   JOURNAL OF CLINICAL ONCOLOGY

EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes

(2016) Saravana Kumar Kailasam Mani et al.   JOURNAL OF HEPATOLOGY

Core protein: A pleiotropic keystone in the HBV lifecycle

(2015) Adam Zlotnick et al.   ANTIVIRAL RESEARCH

PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus–Induced Liver Carcinogenesis

(2015) Hao Zhang et al.   CANCER RESEARCH

Early inhibition of hepatocyte innate responses by hepatitis B virus

(2015) Souphalone Luangsay et al.   JOURNAL OF HEPATOLOGY

Mumps Virus Nucleoprotein Enhances Phosphorylation of the Phosphoprotein by Polo-Like Kinase 1

(2015) Adrian Pickar et al.   JOURNAL OF VIROLOGY

Understanding the Polo Kinase machine

(2015) V Archambault et al.   ONCOGENE

Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment

(2015) Xiaoqi Liu   Translational Oncology

Antiviral Therapies and Prospects for a Cure of Chronic Hepatitis B

(2015) F. Zoulim et al.   Cold Spring Harbor Perspectives in Medicine

Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer

(2015) Joshua A. McCarroll et al.   Oncotarget

Regulation of Multiple Stages of Hepadnavirus Replication by the Carboxyl-Terminal Domain of Viral Core Protein in trans

(2014) Kuancheng Liu et al.   JOURNAL OF VIROLOGY

Natural history of chronic hepatitis B virus infection

(2014) Katrin Busch et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA

(2014) J. Lucifora et al.   SCIENCE

Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein

(2012) Leo L. Studach et al.   HEPATOLOGY

Cyclin-Dependent Kinase 2 Phosphorylates S/T-P Sites in the Hepadnavirus Core Protein C-Terminal Domain and Is Incorporated into Viral Capsids

(2012) L. Ludgate et al.   JOURNAL OF VIROLOGY

Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication

(2011) Wen-Horng Wang et al.   HEPATOLOGY

Secretion of Genome-Free Hepatitis B Virus – Single Strand Blocking Model for Virion Morphogenesis of Para-retrovirus

(2011) Xiaojun Ning et al.   PLoS Pathogens

Polo-like Kinase 1 Activated by the Hepatitis B Virus X Protein Attenuates Both the DNA Damage Checkpoint and DNA Repair Resulting in Partial Polyploidy

(2010) Leo Studach et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment

(2010) Karl-Dimiter Bissig et al.   JOURNAL OF CLINICAL INVESTIGATION

Polo-Like Kinase 1 Is Involved in Hepatitis C Virus Replication by Hyperphosphorylating NS5A

(2010) Y.-C. Chen et al.   JOURNAL OF VIROLOGY

The Arginine Clusters of the Carboxy-Terminal Domain of the Core Protein of Hepatitis B Virus Make Pleiotropic Contributions to Genome Replication

(2010) E. B. Lewellyn et al.   JOURNAL OF VIROLOGY

Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy

(2010) Klaus Strebhardt   NATURE REVIEWS DRUG DISCOVERY

Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression

(2009) Leo L. Studach et al.   HEPATOLOGY

PLK1 Down-Regulates Parainfluenza Virus 5 Gene Expression

(2009) Dengyun Sun et al.   PLoS Pathogens

Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells

(2008) O. Hantz et al.   JOURNAL OF GENERAL VIROLOGY